Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Evaluation of the safety and efficacy of using human menstrual blood‐derived mesenchymal stromal cells in treating severe and critically ill COVID‐19 patients: An exploratory clinical trial

PaperCitations, authors & open-access status

Evaluation of the safety and efficacy of using human menstrual blood‐derived mesenchymal stromal cells in treating severe and critically ill COVID‐19 patients: An exploratory clinical trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 133 citations, 2021 year and gold oa status.

133
Citations
2021
Year
gold
OA Status

Related on ScholarIQ

Jingjing Qu
Author
COVID-19 and healthcare impacts
Topic
COVID-19 and healthcare impacts
Topic
Mesenchymal stem cell research
Topic
COVID-19 Clinical Research Studies
Topic
470M+ articles · free account